{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:34:43Z","timestamp":1790739283731,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Farnesoid-X-Receptor (FXR) plays a central role in maintaining bile acid (BA) homeostasis by transcriptional control of numerous enterohepatic genes, including intestinal FGF19, a hormone that strongly represses hepatic BA synthesis. How activation of the FGF19 receptor at the membrane is transmitted to the nucleus for transcriptional regulation of BA levels and whether FGF19 signaling posttranslationally modulates FXR function remain largely unknown. Here we show that FXR is phosphorylated at Y67 by non-receptor tyrosine kinase, Src, in response to postprandial FGF19, which is critical for its nuclear localization and transcriptional regulation of BA levels. Liver-specific expression of phospho-defective Y67F-FXR or Src downregulation in mice results in impaired homeostatic responses to acute BA feeding, and exacerbates cholestatic pathologies upon drug-induced hepatobiliary insults. Also, the hepatic FGF19-Src-FXR pathway is defective in primary biliary cirrhosis (PBC) patients. This study identifies Src-mediated FXR phosphorylation as a potential therapeutic target and biomarker for BA-related enterohepatic diseases.<\/jats:p>","DOI":"10.1038\/s41467-018-04697-5","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T08:18:22Z","timestamp":1530087502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5101-8372","authenticated-orcid":false,"given":"Sangwon","family":"Byun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ryerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5130-4413","authenticated-orcid":false,"given":"Young-Chae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8200-7817","authenticated-orcid":false,"given":"Bo","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Eric","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongsook Kim","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"key":"4697_CR1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cphy.c120023","volume":"3","author":"JY Chiang","year":"2013","unstructured":"Chiang, J. Y. Bile acid metabolism and signaling. Compr. Physiol. 3, 1191\u20131212 (2013).","journal-title":"Compr. Physiol."},{"key":"4697_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00010.2008","volume":"89","author":"P Lefebvre","year":"2009","unstructured":"Lefebvre, P., Cariou, B., Lien, F., Kuipers, F. & Staels, B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev. 89, 147\u2013191 (2009).","journal-title":"Physiol. Rev."},{"key":"4697_CR3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/sj.emboj.7601049","volume":"25","author":"SM Houten","year":"2006","unstructured":"Houten, S. M., Watanabe, M. & Auwerx, J. Endocrine functions of bile acids. EMBO J. 25, 1419\u20131425 (2006).","journal-title":"EMBO J."},{"key":"4697_CR4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J. & Schoonjans, K. Targeting bile-acid signalling for metabolic diseases. Nat. Rev. Drug Discov. 7, 678\u2013693 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"4697_CR5","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1194\/jlr.R900007-JLR200","volume":"50","author":"PB Hylemon","year":"2009","unstructured":"Hylemon, P. B. et al. Bile acids as regulatory molecules. J. Lipid Res. 50, 1509\u20131520 (2009).","journal-title":"J. Lipid Res."},{"key":"4697_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00001574-200405000-00006","volume":"20","author":"M Trauner","year":"2004","unstructured":"Trauner, M. & Boyer, J. L. Cholestatic syndromes. Curr. Opin. Gastroenterol. 20, 220\u2013230 (2004).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"4697_CR7","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1194\/jlr.R049437","volume":"55","author":"AF Hofmann","year":"2014","unstructured":"Hofmann, A. F. & Hagey, L. R. Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades. J. Lipid Res. 55, 1553\u20131595 (2014).","journal-title":"J. Lipid Res."},{"key":"4697_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","volume":"157","author":"RM Evans","year":"2014","unstructured":"Evans, R. M. & Mangelsdorf, D. J. Nuclear receptors, RXR, and the big bang. Cell 157, 255\u2013266 (2014).","journal-title":"Cell"},{"key":"4697_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm3312","volume":"13","author":"AC Calkin","year":"2012","unstructured":"Calkin, A. C. & Tontonoz, P. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat. Rev. Mol. Cell Biol. 13, 213\u2013224 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"4697_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","volume":"17","author":"TQ de Aguiar Vallim","year":"2013","unstructured":"de Aguiar Vallim, T. Q., Tarling, E. J. & Edwards, P. A. Pleiotropic roles of bile acids in metabolism. Cell Metab. 17, 657\u2013669 (2013).","journal-title":"Cell Metab."},{"key":"4697_CR11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature13961","volume":"516","author":"JM Lee","year":"2014","unstructured":"Lee, J. M. et al. Nutrient-sensing nuclear receptors coordinate autophagy. Nature 516, 112\u2013115 (2014).","journal-title":"Nature"},{"key":"4697_CR12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature13949","volume":"516","author":"S Seok","year":"2014","unstructured":"Seok, S. et al. Transcriptional regulation of autophagy by an FXR-CREB axis. Nature 516, 108\u2013111 (2014).","journal-title":"Nature"},{"key":"4697_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.cmet.2015.01.007","volume":"21","author":"TQ de Aguiar Vallim","year":"2015","unstructured":"de Aguiar Vallim, T. Q. et al. MAFG is a transcriptional repressor of bile acid synthesis and metabolism. Cell Metab. 21, 298\u2013310 (2015).","journal-title":"Cell Metab."},{"key":"4697_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/hep.27677","volume":"62","author":"YC Kim","year":"2015","unstructured":"Kim, Y. C. et al. FXR-induced lysine-specific histone demethylase, LSD1, reduces hepatic bile acid levels and protects the liver against bile acid toxicity. Hepatology 62, 220\u2013231 (2015).","journal-title":"Hepatology"},{"key":"4697_CR15","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.15252\/embj.201695500","volume":"36","author":"S Byun","year":"2017","unstructured":"Byun, S. et al. A postprandial FGF19-SHP-LSD1 regulatory axis mediates epigenetic repression of hepatic autophagy. EMBO J. 36, 1755\u20131769 (2017).","journal-title":"EMBO J."},{"key":"4697_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1210\/me.2015-1226","volume":"30","author":"T Fu","year":"2015","unstructured":"Fu, T. et al. FXR primes the liver for intestinal FGF15 signaling by transient induction of betaKlotho. Mol. Endocrinol. 30, 92\u2013103 (2015).","journal-title":"Mol. Endocrinol."},{"key":"4697_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000371670","volume":"33","author":"SA Kliewer","year":"2015","unstructured":"Kliewer, S. A. & Mangelsdorf, D. J. Bile acids as hormones: the FXR-FGF15\/19 pathway. Dig. Dis. 33, 327\u2013331 (2015).","journal-title":"Dig. Dis."},{"key":"4697_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","volume":"368","author":"T Matsubara","year":"2013","unstructured":"Matsubara, T., Li, F. & Gonzalez, F. J. FXR signaling in the enterohepatic system. Mol. Cell. Endocrinol. 368, 17\u201329 (2013).","journal-title":"Mol. Cell. Endocrinol."},{"key":"4697_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2016.08.001","volume":"166","author":"CD De Magalhaes Filho","year":"2016","unstructured":"De Magalhaes Filho, C. D., Downes, M. & Evans, R. Bile acid analog intercepts liver fibrosis. Cell 166, 789 (2016).","journal-title":"Cell"},{"key":"4697_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","volume":"2","author":"T Inagaki","year":"2005","unstructured":"Inagaki, T. et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2, 217\u2013225 (2005).","journal-title":"Cell Metab."},{"key":"4697_CR21","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.cmet.2015.05.004","volume":"21","author":"T Katafuchi","year":"2015","unstructured":"Katafuchi, T. et al. Detection of FGF15 in plasma by stable isotope standards and capture by anti-peptide antibodies and targeted mass spectrometry. Cell Metab. 21, 898\u2013904 (2015).","journal-title":"Cell Metab."},{"key":"4697_CR22","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1126\/science.1198363","volume":"331","author":"S Kir","year":"2011","unstructured":"Kir, S. et al. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 331, 1621\u20131624 (2011).","journal-title":"Science"},{"key":"4697_CR23","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/hep.25740","volume":"56","author":"B Kong","year":"2012","unstructured":"Kong, B. et al. Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology 56, 1034\u20131043 (2012).","journal-title":"Hepatology"},{"key":"4697_CR24","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1172\/JCI23076","volume":"115","author":"S Ito","year":"2005","unstructured":"Ito, S., Fujimori, T., Furuya, A., Satoh, J. & Nabeshima, Y. Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho. J. Clin. Invest. 115, 2202\u20132208 (2005).","journal-title":"J. Clin. Invest."},{"key":"4697_CR25","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.bbadis.2010.11.011","volume":"1812","author":"JK Kemper","year":"2011","unstructured":"Kemper, J. K. Regulation of FXR transcriptional activity in health and disease: emerging roles of FXR cofactors and post-translational modifications. Biochim. Biophys. Acta 1812, 842\u2013850 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"4697_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cmet.2009.09.009","volume":"10","author":"JK Kemper","year":"2009","unstructured":"Kemper, J. K. et al. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab. 10, 392\u2013404 (2009).","journal-title":"Cell Metab."},{"key":"4697_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.15252\/embj.201489527","volume":"34","author":"DH Kim","year":"2015","unstructured":"Kim, D. H. et al. A dysregulated acetyl\/SUMO switch of FXR promotes hepatic inflammation in obesity. EMBO J. 34, 184\u2013199 (2015).","journal-title":"EMBO J."},{"key":"4697_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12179","volume":"7","author":"DH Kim","year":"2016","unstructured":"Kim, D. H. et al. Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis. Nat. Commun. 7, 12179 (2016).","journal-title":"Nat. Commun."},{"key":"4697_CR29","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cmet.2014.07.023","volume":"20","author":"S Stein","year":"2014","unstructured":"Stein, S. et al. SUMOylation-dependent LRH-1\/PROX1 interaction promotes atherosclerosis by decreasing hepatic reverse cholesterol transport. Cell Metab. 20, 603\u2013613 (2014).","journal-title":"Cell Metab."},{"key":"4697_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03060-y","volume":"9","author":"YC Kim","year":"2018","unstructured":"Kim, Y. C. et al. AhR and SHP regulate phosphatidylcholine and S-adenosylmethionine levels in the one-carbon cycle. Nat. Commun. 9, 540 (2018).","journal-title":"Nat. Commun."},{"key":"4697_CR31","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1365-2796.2006.01731.x","volume":"260","author":"T Lundasen","year":"2006","unstructured":"Lundasen, T., Galman, C., Angelin, B. & Rudling, M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J. Intern. Med. 260, 530\u2013536 (2006).","journal-title":"J. Intern. Med."},{"key":"4697_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225\u2013235 (2013).","journal-title":"Cell Metab."},{"key":"4697_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/j.gastro.2011.10.028","volume":"142","author":"S Modica","year":"2012","unstructured":"Modica, S. et al. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Gastroenterology 142, 355\u2013365 (2012).","journal-title":"Gastroenterology"},{"key":"4697_CR34","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1172\/JCI68815","volume":"124","author":"F Lien","year":"2014","unstructured":"Lien, F. et al. Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk. J. Clin. Invest. 124, 1037\u20131051 (2014).","journal-title":"J. Clin. Invest."},{"key":"4697_CR35","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nrc1366","volume":"4","author":"TJ Yeatman","year":"2004","unstructured":"Yeatman, T. J. A renaissance for SRC. Nat. Rev. Cancer 4, 470\u2013480 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"4697_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2005.03.012","volume":"331","author":"R Roskoski Jr.","year":"2005","unstructured":"Roskoski, R. Jr. Src kinase regulation by phosphorylation and dephosphorylation. Biochem. Biophys. Res. Commun. 331, 1\u201314 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"4697_CR37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cmet.2014.05.020","volume":"20","author":"S Li","year":"2014","unstructured":"Li, S. et al. Cytoplasmic tyrosine phosphatase Shp2 coordinates hepatic regulation of bile acid and FGF15\/19 signaling to repress bile acid synthesis. Cell Metab. 20, 320\u2013332 (2014).","journal-title":"Cell Metab."},{"key":"4697_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/hep.22627","volume":"49","author":"KH Song","year":"2009","unstructured":"Song, K. H., Li, T., Owsley, E., Strom, S. & Chiang, J. Y. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology 49, 297\u2013305 (2009).","journal-title":"Hepatology"},{"key":"4697_CR39","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1074\/jbc.M111.305789","volume":"287","author":"T Li","year":"2012","unstructured":"Li, T. et al. Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity. J. Biol. Chem. 287, 1861\u20131873 (2012).","journal-title":"J. Biol. Chem."},{"key":"4697_CR40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.tcb.2014.11.003","volume":"25","author":"EP Carter","year":"2015","unstructured":"Carter, E. P., Fearon, A. E. & Grose, R. P. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction. Trends Cell Biol. 25, 221\u2013233 (2015).","journal-title":"Trends Cell Biol."},{"key":"4697_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/srep13462","volume":"5","author":"E Wunsch","year":"2015","unstructured":"Wunsch, E. et al. Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease. Sci. Rep. 5, 13462 (2015).","journal-title":"Sci. Rep."},{"key":"4697_CR42","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1101\/gad.1773909","volume":"23","author":"J Miao","year":"2009","unstructured":"Miao, J. et al. Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation. Genes Dev. 23, 986\u2013996 (2009).","journal-title":"Genes Dev."},{"key":"4697_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10713","volume":"7","author":"N Gomez-Ospina","year":"2016","unstructured":"Gomez-Ospina, N. et al. Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis. Nat. Commun. 7, 10713 (2016).","journal-title":"Nat. Commun."},{"key":"4697_CR44","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1073\/pnas.1106799109","volume":"109","author":"K Chellappa","year":"2012","unstructured":"Chellappa, K. et al. Src tyrosine kinase phosphorylation of nuclear receptor HNF4alpha correlates with isoform-specific loss of HNF4alpha in human colon cancer. Proc. Natl Acad. Sci. USA 109, 2302\u20132307 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4697_CR45","doi-asserted-by":"publisher","first-page":"23252","DOI":"10.1074\/jbc.M113.452037","volume":"288","author":"S Seok","year":"2013","unstructured":"Seok, S. et al. Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Czeta is critical for epigenomic regulation of liver metabolic genes. J. Biol. Chem. 288, 23252\u201323263 (2013).","journal-title":"J. Biol. Chem."},{"key":"4697_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.3760","volume":"21","author":"S Fang","year":"2015","unstructured":"Fang, S. et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat. Med. 21, 159\u2013165 (2015).","journal-title":"Nat. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04697-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04697-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04697-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T10:14:06Z","timestamp":1671531246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04697-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["4697"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-04697-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"11 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2590"}}